Etiometry's solutions provide healthcare
professionals with actionable intelligence, setting new benchmarks
in critical care treatment.
SAN ANTONIO, May 21, 2024 /PRNewswire/ -- Frost &
Sullivan recently researched the clinical decision support for
critical care industry and, based on its findings, recognizes
Etiometry with the 2024 North American Enabling Technology
Leadership Award. Etiometry is a leading provider of clinical
decision-support software for the intensive care unit (ICU)
environment, revolutionizing the industry with its unique software
and application.
Etiometry's software solutions deliver actionable insights to
healthcare professionals. The company offers the first and only
clinical decision support technology with explicit Food and Drug
Administration (FDA) clearance for use at the bedside for patient
monitoring. This FDA-approved platform offers essential data
visualization and analytics that support clinical decisions in ICU
environments. These innovations dramatically enhance patient
outcomes and increase hospital throughput and financial
performance, expanding the software's powerful impact on healthcare
quality and economic efficiency.
"Etiometry's complex multi-variate continuously learning
mathematical model of human physiology leverages multi-variant
equations to model the key aspects of physiology, such as cardiac
status, pulmonary mechanics, and acid/base balance, to enable care
pathways. The company offers multiple FDA-cleared risk algorithms
and analytics-powered automated clinical pathways, which give
clinicians quicker access to patient data and enable more effective
care decisions," said Dr. Rishi
Pathak, Research Director, Healthcare & Life Sciences at
Frost & Sullivan.
By enhancing the ability to monitor and adjust treatments
rapidly, Etiometry can help care teams reduce patient time on
ventilators and vasoactive medications, decrease ICU readmissions,
and shorten hospital stays. Moreover, the platform's integration
into existing hospital workflows is seamless, ensuring that the
tools are accessible within the established practices, including
the EHR. The platform facilitates a holistic view of patient health
status, without disrupting the workflow of medical staff.
"Moreover, since most hospitals are operating at 100% capacity,
by reducing the time spent in the ICU and overall length of stay,
hospitals can boost overall throughput, increasing potential
revenue and thereby impacti ROI. Etiometry's advanced Clinical
Pathways and algorithms have led to an up to 22% reduction in time
on ventilation, up to a 36% reduction in length of stay, and a
decrease in ICU readmission by up to 41%," noted Michelle Funke, Best Practices Research Analyst
at Frost & Sullivan.
Etiometry's disruptive solutions in the ICU streamline patient
care by reducing the time patients spend on mechanical ventilation
and their overall length of stay in the ICU. By automating the
organization and assimilation of information, the solution
simplifies clinicians' workloads and enables hospitals to
accommodate more patients, thereby maximizing operational capacity
and enhancing financial performance. The company's sophisticated
solutions, therefore, contribute to a better return on investment
for hospitals because they can save on costs in the most complex
and expensive units in the hospital ,while serving more patients
with the same or even fewer resources.
Furthermore, with its commitment to continual improvement and
adaptation to user feedback, the company is well positioned as a
leader in healthcare technology. The company maintains an ongoing
dialogue with clinicians and integrates their input into software
updates and features. As a result, this approach ensures that
Etiometry's solutions remain at the forefront of technological
advancements and meet the evolving needs of the healthcare
industry.
Each year, Frost & Sullivan presents this award to a company
that develops a pioneering technology that enhances current
products and enables new product and application development. The
award recognizes the high market acceptance potential of the
recipient's technology.
Frost & Sullivan Best Practices Awards recognize companies
in various regional and global markets for demonstrating
outstanding achievement and superior performance in leadership,
technological innovation, customer service, and strategic product
development. Industry analysts compare market participants and
measure performance through in-depth interviews, analyses, and
extensive secondary research to identify best practices in the
industry.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned
for its role in helping investors, corporate leaders, and
governments navigate economic changes and identify disruptive
technologies, Mega Trends, new business models, and companies to
action, resulting in a continuous flow of growth opportunities to
drive future success. Contact us: Start the discussion.
Contact:
Ashley Shreve
ashley.weinkauf@frost.com
About Etiometry
Founded in 2010, Etiometry is a leader
in clinical decision-support software designed to help clinicians
in the intensive care setting make data-based decisions regarding
their patients' care and treatment. The company's technologies
provide valuable clinical insight and analysis to support early
recognition of subtle changes in patients' conditions to avoid
complications and speed recovery. With roots in pediatric ICUs,
Etiometry's software is utilized in more than 30 of the top U.S.
children's hospitals and now in a growing number of top adult
hospitals. Etiometry is committed to improving patient outcomes,
increasing clinical efficiency, and lowering the cost of care
through the more effective use of data. To learn more,
visit www.etiometry.com.
Photo -
https://mma.prnewswire.com/media/2417381/Frost_and_Sullivan__Etiometry_Award.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/etiometry-awarded-frost--sullivans-2024-north-american-enabling-technology-leadership-award-for-leading-innovation-in-clinical-decision-support-systems-302150919.html